Anti-viral drugs Market is expected to register a Healthy CAGR of 6.9% during 2018-2027

 

Global Anti-viral drugs Market Information, by application (hepatitis, HIV/AIDS, herpes, influenza and others) and by mechanism of action (nucleotide polymerase inhibitors, reverse transcriptase inhibitors, protease inhibitors and others) - Forecast to 2022

 

Overview

 

The anti-viral drugs market companies is anticipated to grow by US$62.67 by 2022 rapidly growing at a CAGR of 6.9% during the forecast period. The global anti-viral drugs market is driven by rise in healthcare expenditure and emergence of life-threatening diseases. These factors have helped shape the anti-viral drugs market and are expected to boost the growth. Companies in the anti-viral drugs market could also face challenges such as lack of awareness and shortage of skilled professionals. The details covered in the anti-viral drugs market report cover all the aspects of the industry. Anti-viral drugs market analysts have also shared growth projections in the report and have suggested anti-viral drugs market players to plan growth strategies accordingly.

 

Market Segmentation

 

The global anti-viral drugs market has been segmented based on mechanism of action and application. On the basis of applications, the market for anti-viral drugs is segmented based on herpes, HIV/AIDS, influenza, hepatitis, and others. Additionally, the market on the basis of mechanism of action, is segmented into nucleotide polymerase inhibitors, protease inhibitors, reverse transcriptase inhibitors, and others.

 

Factors like growing research and development investment and increasing incidence rates of viral infections support the anti-viral drugs market growth. The performance of anti-viral drugs market has also been studied for the past and current years. Additionally, the anti-viral drugs market report provides analysis of these segments. The anti-viral drugs market segmental analysis provided in the report offers major details about the anti-viral drugs market performance and future.

 

Regional Overview

 

Companies in the anti-viral drugs market are spread across the world. The anti-viral drugs market report provides major information about regional markets of North America, Europe, Asia-Pacific (APAC), and the rest of the world. The North American anti-viral drugs market has many companies across the United States, Canada, and Mexico. Europe has companies in the anti-viral drugs market across Germany, France, Spain, Italy, and the United Kingdom. A detailed analysis of the anti-viral drugs market across India, China, and Japan in the Asia-Pacific region is also presented in the report. The anti-viral drugs market of the Middle East, Africa, and other regions has also been studied by analysts. The regional analysis of the anti-viral drugs market can be found in the market research report.

 

Competitive Landscape

 

The anti-viral drugs market is supported by growing research and development investment. The population growth around the world and increasing demand of anti-viral drugs market based services and products also support the market growth. However, changes in policies and lack of clarity in guidelines can affect the market growth. The report covers all such details which will help companies in the anti-viral drugs market to strengthen their business plan and improve their product portfolio. The anti-viral drugs market research report also provides company profiles of major companies. The company profiles of many organizations operating in the anti-viral drugs market report highlights crucial details like company size, revenue growth, and details of mergers and acquisitions taking place in the anti-viral drugs market. New companies and established businesses can plan their strategies based on this data provided in the anti-viral drugs market research report.

 

Industry News

 

NeuroBo Pharmaceuticals, a biotechnology firm, has announced that it has purchased ANA Therapeutics, a privately owned biotechnology company that produces a patented niclosamide capsule formulation for the indication of coronavirus, now in Phase 2/3 clinical trials as a cure for COVID-19. The deal was unanimously approved by both the Boards of Directors of NeuroBo Pharmaceuticals and ANA Therapeutics.

 

Read More @ https://www.marketresearchfuture.com/reports/anti-viral-drugs-market-2454

 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Blog: https://healthcarenews12.blogspot.com/

Cranial Fixation and Stabilization Market- Regional Demand and Analysis to Forecast by 2023

Market Overview

The Global Cranial Fixation and Stabilization Market is expected to reach USD 2.29 Billion by 2025, registering a CAGR of 8.90%.

This market growth can be attributed to the growing healthcare market and the ever-expanding technology market. Advances in these fields have created an environment that is conducive to the development of specialized surgical procedures for traditionally high-risk surgeries.

According to the UN, globally, one in six individuals suffers from a neurological disorder. There are several invasive surgeries that being developed to treat such conditions, requiring cranial fixation and stabilization equipment.

SEGMENTATION

By Category

Cranial stabilization equipment is used to secure the head during surgery, while cranial fixation implements are tools required to maintain the structural stability of the head and neck.

Cranial Fixation Systems: Cranial fixation covers a wide array of tools and implements such as meshes, flap tube clamps, plates, and screws to be used during surgery. They are used predominantly for affixing bones, securing skin, and enhancing cranial integrity post-surgeries such as craniotomies.

Cranial Stabilization Systems: Cranial surgeries are usually very delicate and complex, necessitating the use of equipment to immobilize the head. This is accomplished by the use of cranial stabilization equipment such as skull clamps and horseshoe headrests.

 Get Free Sample @https://www.marketresearchfuture.com/sample_request/8163  

By Product

Meshes: The leading market segment as 48% of all cranial injuries are maxillofacial. Over 52% of road accident-related injuries are mandibular fractures that require meshes.

Skull Clamps: Ideal for prolonged surgeries that require patient immobilization for long periods with limited soft tissue damage. Used to hold the head firmly in place during surgery.

Flap Tube Clamps: Used to attach cranial bones to the cranium during delicate surgeries when only a singular motion can be performed upon the afflicted area.

Horseshoe Headrests: Used in cases where head movement is not to be completely restrained and soft tissue damage needs to be minimized.

Plates: Used to seal gaping cranial wounds.

Screws: Facilitate the attachment of cranial bones.

Accessories: Include patient positioning systems and support systems.

By Type

Resorbable: Materials that are eventually broken down by the body. The growth of the segment is limited by the high costs of the equipment.

Non-Resorbable: These are biocompatible and offer unparalleled rigidity and stability to the cranium. Used extensively in developing countries due to their low costs.

By End User

Hospitals: The segment commands the largest share of the global cranial fixation and stabilization market as most cranial surgeries are performed in hospitals. Cranial surgeries require the latest equipment and amenities, along with a high level of expertise, which are offered by hospitals.

Ambulatory Surgical Centers: As emergency and temporary patient-stabilization surgeries are performed at these centers, the segment accounts for a small market share, which is somewhat offset by the higher revenue per surgery generated.

Others: This segment includes on-site trauma and emergency surgeries. This is a niche segment with growth potential due to the establishment of trauma centers at industrial complexes.

 By Region

Americas: Largest regional market, with North America accounting for 55% of the global market share.

Asia-Pacific: Fastest growing regional market

Europe: Second-largest market

Middle East & Africa

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/cranial-fixation-stabilization-market-8163

Key Players

Johnson & Johnson (US)

Stryker (US)

Ostomed (UK)

KLS Martin Group (Germany)

Medtronic (US)

Integra LifeSciences Corporation (US)

Braun Melsungen AG (Germany)

Changzhou Huida (China)

DePuy Synthes (US)

Evonos (Germany)

Jeil Medical (South Korea)

Medicon (Germany)

Micromar (Brazil)

NEOS Surgery (Spain)

Pro Med Instruments (Germany)

Zimmer Biomet (US)

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Blog: https://healthcarenews12.blogspot.com/ 

Veterinary Imaging Market- Trends, Global Demand and Report

 Market Insights:

The evolvement of pet insurance has made vet fees affordable which has propelled the demand for advanced diagnosis and veterinary imaging tests. Market Research Future (MRFR) has asserted in its latest report that the global veterinary imaging market will expand throughout the forecast period 2017 to 2023 at 6.9% CAGR. The global market was valued at USD 1.24 Bn in 2017 and is projected to reach a valuation of USD 1.85 Bn by the end of 2023.

Global Veterinary Imaging Market  - Overview

The global veterinary imaging market has been evaluated as steadily growing market and it is expected that the market will continue to grow similarly in the near future. Veterinary deals with diagnosis and treatment of diseases in animals. Veterinary imaging devices are useful in diagnosis and treatment of diseases in animals. These devices also gives clear understanding of disease or injury that helps veterinarian for treatment of animal. Increasing awareness about animal healthcare and improvement of animal life are key factors for the growth of the market. Disease pattern in animals are continuously changing and becoming more challenging for veterinarians to diagnose these diseases. Veterinary imaging devices gives them in accurate diagnosis and further treatment. Increasing pet adoption is another major factor for the growth of the market. Increasing number of veterinarians, veterinary clinics and growing veterinary healthcare infrastructure are driving the growth for the market. Cattle are very important part of farming that have economic importance because they provides many products like milk, meat and leather. Farmers are becoming more aware about the health of their cattle which is good sign for the growth of the market. About 75% of veterinarians are working in private hospitals or pet clinics and these hospitals or clinics are spending money in advancement of technology to provide better facilities. Veterinary imaging devices manufacturers are spending money to develop innovative and usable product for the market. However there are some factors are inhibiting the growth of the market such as high cost of devices that small clinics cannot afford, lack of knowledge about new technology or products, availability of products, access to veterinary healthcare facilities, lack of skilled veterinary professionals etc.

Get Free Sample @ https://www.marketresearchfuture.com/sample_request/2919       

Global Veterinary Imaging Market - Regional Analysis

Depending on geographic region, veterinary imaging market is segmented into four key regions: Americas, Europe, Asia-Pacific, and Middle East & Africa. Considering the global scenario of the market, North America holds be the largest market for veterinary imaging due to increasing awareness about animal healthcare and increasing investment in healthcare domain. Moreover the European market is also growing and second largest market for Veterinary Imaging. On the other hand, Asia-Pacific market is expected to grow at the fastest pace in the Veterinary Imaging during the forecasted period. Whereas, The Middle East & Africa have the least market share. Additionally, factors such as lack of awareness, low healthcare expenditures will restrain the market during the corresponding period.

Top Companies:

Atlantis Worldwide (US), Canon Inc. (Japan), Diagnostic Imaging Systems, Inc. (US), Fujifilm Holdings Corporation (Japan), GE Healthcare (US), Hitachi, Ltd (Japan), Medical Imaging / IMCO, Inc. (US), Sectra (Sweden), Siemens AG (Germany), Toshiba Medical Systems Corporation (Japan) are some of the prominent players at the forefront of competition in the Global Veterinary Imaging Market and are profiled in MRFR Analysis. 

Global Veterinary Imaging Market  - Competitive Analysis

Characterized by the presence of several well-established and small players, the global market of veterinary imaging appears to be highly competitive and fragmented. Major market players who are increasingly expanding their footprint in the developing economy, making it difficult for regional vendors to compete with them, especially in terms of features such as product differentiation, product portfolios, quality, and pricing.  The Market is witnessing intensified competition which is expected to get more intensified further during the forecast period. The intense competition prevalent in the market dictates the consolidation among marketers. Therefore, key players ensure that their portfolio includes products both for treating sick animals and for preventing disease occurrence.

December, 2015 - Fujifilm and Anicom Holdings, Inc. entered into partnership and established joint venture for developing and providing cutting-edge veterinary technologies and services with focus on regenerative medicine. According to company reports, it had developed advanced veterinary medicine by combining Fujifilm's advanced production engineering and quality control technology nurtured in its photographic film business as well as diagnostic imaging technology, blood's chemical composition analysis technology and regenerative medical technology, with Anicom's veterinary hospital network, electronic medical record system and extensive animal treatment data. Moreover, the company had conducted science-based clinical research such as regenerative medicine including cell therapies.

Well established players incorporate acquisition, collaboration, partnership, expansion, and product launch in order to gain competitive advantage in this market and to maintain their market position.

Report Details @ https://www.marketresearchfuture.com/reports/veterinary-imaging-market-2919

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Blog: https://healthcarenews12.blogspot.com/

Elastography Imaging Market Trends, Global Analysis and Forecast

 Elastography Imaging Market Analysis 

The global elastography imaging market is estimated to grow at an 11.1% CAGR between 2019-2025, reveals the new Market Research Future (MRFR) report. Elastography, simply put, is a medical imaging mode that maps the stiffness & elastic properties of soft tissue. Owing to its magnificent features, elastography imaging has wide applications in orthopedic and musculoskeletal applications, vascular, urology, obstetrics/gynecology, cardiology, radiology/general imaging, and others.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/8070 

Numerous factors are adding to the global elastography imaging market growth. Such factors, according to the recent MRFR report, include the growing demand for effective therapies for treating complicated disorders, changes in regulatory policies, increasing incidence of life-threatening diseases, and burgeoning demand for procedures that are minimally invasive to diagnose as well as treat various chronic diseases. 

On the contrary, the high price of systems may limit the global elastography imaging market growth over the forecast period. 

Regional Analysis 

By region, the global elastography imaging market report covers the growth opportunities and recent trends across Europe, the Americas, the Middle East & Africa (MEA), and the Asia Pacific (APAC). Of these, the Americas will have the lions share in the market over the forecast period. Factors adding to the global elastography imaging market growth in the region include the increasing use of new technology, rising per capita healthcare expenditure, and increasing expenditure by healthcare bodies in research. Canada and the United States are the key contributors in the region for improving reimbursement scenario and a rise in insurance coverage. 

The global elastography imaging market in Europe is predicted to hold the second-largest share over the forecast period for the involvement of top companies, rise in chronic diseases, and the presence of an established healthcare system. 

The global elastography imaging market in the APAC region will have steady growth over the forecast period for the favorable initiatives undertaken by the government for healthcare reforms and the rising prevalence of chronic diseases. Meanwhile, a fall in capital investment may hinder the market growth. 

The global elastography imaging market in the MEA will have a small share during the forecast period for the region’s low disposable income and limited access to medical treatment facilities. 

Market Segmentation

The MRFR report provides an inclusive segmental analysis of the global elastography imaging market based on end user, application, and modality. 

By modality, the elastography imaging market is segmented into magnetic resonance elastography (MRI) and ultrasound. Of these, the ultrasound segment will lead the market over the forecast period for the plentiful benefits that it offers. Meanwhile, magnetic resonance elastography will grow at the fastest pace for its increasing adoption rate and wider availability. 

By application, the elastography imaging market is segmented into orthopedic and musculoskeletal applications, vascular, urology, obstetrics/gynecology, cardiology, radiology/general imaging, and others. Of these, radiology/general imaging will dominate the market over the forecast period for the rising prevalence of chronic diseases worldwide. Meanwhile, the cardiology segment will grow at the fastest pace over the forecast period for the increase in the patient population. 

By end user, the elastography imaging market is segmented into research laboratories, diagnostic centers, hospitals and ambulatory surgical centers, and others. Of these, hospitals and ambulatory surgical centers will have a major share in the market over the forecast period. Rising number of hospitals coupled with the increasing number of hospitalizations are adding market growth. Meanwhile, the diagnostic centers will grow at the fastest pace over the forecast period for inclination towards these centers and increased patient preference. 

 Key Players

Leading players profiled in the global elastography imaging market report include General Electric Company, Supersonic Imagine, Samsung Electronics (Samsung Medison), Koninklijke Philips N.V., Mindray Medical International Ltd., Resoundant Inc., Hitachi Ltd., Esaote, Fujifilm Holdings Corporation, Siemens AG, and Canon Medical Systems Corporation. 

Industry News

November 2019: SimonMed Imaging is the first to provide advanced screening for fatty liver disease. The VIDA 3T MRI helps to detect fibrosis resulting from fatty liver disease or other chronic liver diseases. It uses MRE (magnetic resonance elastography) that combines sound waves with MRI to develop an elastogram (visual map) to show the stiffness of the body tissue, thus offering radiologists with color contrasted clear visual, maximizing accuracy, and limiting error.

Browse Complete Report With Toc@ https://www.marketresearchfuture.com/reports/elastography-imaging-market-8070 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

 

Augmented Reality in Healthcare Industry Size, Share, Future Growth, Competitor Landscape, Topmost Players by 2027

 Augmented Reality in Healthcare Market Analysis

Global augmented reality in healthcare market is anticipated to expand at a whopping 23% CAGR over the assessment period (2017-2023). Augmented reality has gained immense prominence amid medical personnel for different applications including rehabilitation, minimally-invasive surgery and surgical preparation assessment. It has worked wonders in transforming the medical device sector and medicine simultaneously. This is basically a concept where real life elements are enhanced through additional visual information post recognizing the environment for guiding the augmentation which is, positioning and orientating the augmented content. Patients and doctors can use connected gadgets such as a tablet or a smartphone for leveraging this technology and adding valuable data in their treatment and the strides that are made in connected glasses and lenses will make this information access more seamless in the upcoming years. Augmented reality for patients can improve the treatment quality significantly that they get from the healthcare provider. Its key applications in the healthcare domain include fitness management, conducting complex surgeries, pharmacy benefit management, medical training, care management and patient education.

There are myriads of factors that is propelling the augmented reality in healthcare market growth. The different market factors and trends in this market according to an analysis conducted by MRFR (Market Research Future) include advancement in technology, growing need for virtual reality in healthcare, rising workload of healthcare experts, rising regulatory compliance for proper use of augmented reality in the healthcare domain, increasing healthcare expenditure, rising penetration of connected devices, and innovations in medical diagnostics. On the contrary, data security concern and high cost of augmented reality may restrict the demand of the augmented reality in healthcare market during the assessment period.

Avail Free Sample Copy at https://www.marketresearchfuture.com/sample_request/5236

Augmented Reality in Healthcare Market Key Players

Key players profiled in the augmented reality in healthcare market include Virtually Better (U.S.), Magic Leap, Inc. (U.S.), VirtaMed (Switzerland), Osterhout Design Group (U.S.), HTC (Taiwan), Siemens Healthineers (Germany), Blippar (U.K), Philips Healthcare (Netherlands & U.S.), CAE Healthcare (U.S.), Google LLC. (U.S.), Oculus VR (U.S.), Augmedix (U.S.), 3D Systems (U.S.), Medical Realities (U.K), Atheer (U.S.), Wikitude GmbH (Austria), Mindmaze (Switzerland), DAQRI (U.S.), and Microsoft Corporation (U.S.).

Sept 2018 - Researchers at Purdue University have adopted a new method which allows qualified physicians and surgeons across the world in assisting doctors that are less experienced in rural areas, war zones and natural disasters to perform complicated procedures. 

Augmented Reality in Healthcare Market Segmentation

The MRFR report provides an all-inclusive segmental analysis of the augmented reality in healthcare market on the basis of device type, component and application.

Based on component, it is segmented into software, hardware and others. The hardware is further segmented into cameras, position tracker, projectors, displays, sensors and others.

Based on device type, the augmented reality in healthcare market is segmented into handheld device, head mounted display and others.

Based on application, it is segmented into education, medical training, fitness management and others. 

Augmented Reality in Healthcare Market Regional Analysis

Based on region, the augmented reality in healthcare market covers growth opportunities and latest trends across North America, Europe, Asia Pacific and Rest of the World. Of these, North America will remain the foremost region in the market due to the rising use of consumer electronic devices that is fueling the growth of the market considerably. This market in Europe is expected to see a rapid growth during the forecast period. On the other hand, the Asia Pacific nations especially India, Japan and China are emerging markets that is expected to expand at a notable CAGR over the assessment period.

Augmented Reality in Healthcare Market Competitive Analysis

Enrichment in services and products is the key factor that is driving the productivity of the market and also controlling the trends which are gaining distinction in the augmented reality in healthcare market. The gaps present in the market are filled owing to the proper execution of supply chain strategies. Here the predilections of the players and the key success factors are growing consistently by the strategies that are used by the market contenders. The augmented reality in healthcare market’s progress rests in the drivers which are changing the market backdrop radically. The growth is modified in tandem as per the preference of the customer to attain utmost growth along with profitability in the future. Moreover, the launch of new services and products will add an extra impetus in the progress of the market. The growth plans have stimulated this market for prospective new entrants.

Browse Complete Report with TOC at https://www.marketresearchfuture.com/reports/augmented-reality-in-healthcare-market-5236

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

 

 

Breast Biopsy Market 2021 Receives a Rapid Boost in Economy due to High Emerging Demands by Global Industry

 Breast imaging is a diagnostic procedure used in discerning the presence of malignant tumors near the breast in men and women. Some of the procedures include magnetic resonance imaging (MRI), computed tomography (CT), mammography, and others. The global breast imaging market report by Market Research Future (MRFR) contains historical trends and current drivers with an enumerated list of trends, opportunities, and challenges for making it easier for readers to digest the information.

Download free Sample Copy Of Breast Imaging Market @ https://www.marketresearchfuture.com/sample_request/5612 

Breast Imaging Market Overview

The global breast imaging market size can expand at a CAGR of 8.5% from 2017 to 2023 (forecast period) due to rising cases of breast cancer. According to the World Health Organization (WHO), breast cancer is the second biggest form of cancer with more than 200,000 cases being discerned globally.  Technological breakthroughs in diagnostic equipment and increase in healthcare expenditure of developed and developing economies for tackling the disease can work in favor of the market.

Government initiatives for creating awareness among both the genders as well as new imaging methods for conducting faster breast biopsies can drive the market growth. For instance, the SAVI SCOUT technology can be used to pinpoint the exact location of the tumor by surgeons with the help of an infrared reflector. The need for minimally invasive procedures for biopsies can widen the growth prospects of the global breast imaging market.

But the high cost of breast imaging solutions and low awareness levels of breast cancer among women in low-income economies can restrain the market growth.

Breast Imaging Market Regional Analysis

The Middle East & Africa (MEA), Europe, Asia Pacific (APAC), and the Americas are regions taken into consideration during the compilation of the global breast imaging market report. 

The Americas is one of the biggest regions for the market due to high incidence of breast cancer, development of novel imaging devices, and new imaging devices for faster biopsy results. North America, a prominent area within the Americas, is driven by the large use of screening procedures for breast cancer. The changing lifestyles of women and increasing emphasis on women healthcare can drive the regional demand for breast imaging in the Americas market.

The European region is fueled by the inflow of capital accorded to research and development institutes in economies of Germany and the U.K. The growth witnessed in the medical device industry and availability of breast imaging technologies can augur in favor of the global breast imaging market growth.

The APAC region is fueled by numerous opportunities for expansion in Japan, China, and India. Rising number of investments in the healthcare sector combined with awareness of breast cancer can drive the regional demand for breast imaging devices and latest techniques. The immense demand for cost-effective diagnostic solutions as well as the spate of women health awareness programs can bode well for the global breast imaging market.

Breast Imaging Market Segmentation

The global breast imaging market is segmented on the basis of type, application, and end user.

On the basis of type, market is segmented into PET, mammography, CT, MRI, breast biopsy, tactile imaging, ultrasound, and others. Mammography is further segmented into 3D mammography, film-screen mammography, Full-field digital mammography (FFDM), scintimammography or molecular breast imaging, and others. Breast biopsy is further segmented into ultrasound-guided core biopsy, image-guided breast biopsy, tactic core biopsy, and others.

On the basis of application, the market is segmented into metastatic axillary adenocarcinoma, breast cancer diagnosis, post-neoadjuvant chemotherapy, and others.

On the basis of end user, the market is segmented into diagnostic centers, hospitals, and others.

Breast Imaging Market Competition Outlook

Aurora Imaging Technology, Inc., Sonocine, Inc., General Electric Company, Dilon Technologies, Inc., Koninklijke Philips N.V., Gamma Medica, Inc., Toshiba Corporation, Fujifilm Holdings Corporation, Hologic, Inc., Siemens, and others are prominent names in the global breast imaging market. Partnerships are being increasingly seen for players to showcase their latest products. For instance, Fujifilm has inked a partnership contract with Max Healthcare for training doctors in the latest breast imaging technology.

Industry News

Mammography is one of the latest technologies for identifying lesions in heavy breasts. 3D mammography can identify the same with higher efficiency and accuracy and increasing the diagnosis rate. Follow-up exams of women after removal of surgery from breasts are likely to induce the demand for 3D mammography.

Read More About Breast Imaging Market Report @ https://www.marketresearchfuture.com/reports/breast-imaging-market-5612 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Europe Takes the Lead in Biosimilars Market as Lifestyle-Related Disorders Escalate

 Market Scope

Market Research Future (MRFR) expects the biosimilars market to thrive at a rate of 7.5% from 2020 to 2027 (analysis period).

Major Drivers and Impediments

Overall healthcare costs are rising owing to the high-priced pharmaceutical drugs, particularly biologics. Government bodies worldwide are concentrating on lower-priced drug synthesis. The United States spends the most on healthcare and is therefore, working on cutting down on the same. Likewise, price regulations in India and Japan for reducing the health budget have bolstered the demand for cost containment. This scenario has thrown light on the requirement for new affordable and effective therapeutics, which can be favorable for the biosimilars industry in subsequent years.

Get Free Sample @ https://www.marketresearchfuture.com/sample_request/1329

Popular biological drugs are edging towards patent cliff and this can mean substantial profits for the global market. Cost effectiveness of biosimilars, especially compared to the patented biologics and successful outcomes during clinical trials should also benefit the global market. The expanding pharmaceutical sector focused on developing biosimilar drugs can be another key growth booster in the near future.

Market Segmentation

Biosimilars industry can be considered with respect to product, applications, and end users.

The products based on which the market has been split into are recombinant glycosylated proteins, recombinant peptides, and recombinant non-glycosylated proteins. Recombinant non-glycosylated proteins are the biggest segment in the global market, thanks to the soaring cases of chronic disorders ranging from growth hormone deficiency to diabetes. As a result, recombinant non-glycosylated proteins are therapeutically used as they are readily available and are cost-effective.

Application-wise, the biosimilars market caters to chronic diseases, oncology, blood disorders, autoimmune diseases, infectious diseases, growth hormone deficiency, and more. Blood disorders have emerged as the top segment, as a result of the rising burden of the condition worldwide and the increased use of biosimilars by virtue of their low cost and the overall reduction in the treatment cost.

Major end users in the global market are hospitals and clinics as well as research institutes. Hospital and clinics are healthcare settings where treatment options and skilled professionals are easily available, and therefore, have emerged as the leading segment in the global industry.

 

Regional Status

Europe, MEA or Middle East & Africa along with the Americas, APAC or Asia Pacific are the primary markets for biosimilars.

Europe has taken the lead in the global market, as the region houses a vast elderly pool, with close to one fifth of the overall EU population aged more than 65 years. This has given way to several lifestyle-related disorders such as oncology, autoimmune diseases, diabetes, to name a few. Presumably, the scenario has raised the demand for biosimilars and can mean higher market growth over the next few years. In addition to this, numerous blockbuster biologics are on track to lose patent in the coming years, which should present lucrative opportunities to the biosimilar manufacturers.

The North American market displays a bright outlook and can emerge quite lucrative in the coming years, in view of the surging burden of chronic ailments in Canada and the United States. The rising spending on research activities by the healthcare agencies also fuels the market expansion in the region. Favorable reimbursement landscape in the region, especially in the US, encourages healthy competition as it results in lower incentives for the players to compete based on price.

The APAC market is slated to witness considerable growth, with China, South Korea and India offering a host of lucrative opportunities for drug development as well as commercialization. These are generics-driven countries and are known for frequently launching new and advanced manufacturing platforms, which has brought down the costs associated with biosimilar production. In the coming few years, majority of the patent expiries is touted to be in biosimilars, which is deemed as a profitable aspect by leading manufacturers and can translate into substantial market growth.

Eminent Vendors

Top manufacturers of biosimilars in the global industry include Stada Arzneimittel AG (Germany), Teva Pharmaceuticals (Israel), Biocon (India), Pfizer (US), Sandoz International (Germany), Eli Lily & Company (US), Actavis, Inc. (US), Dr. Reddy’s Laboratories (India), Cipla Ltd (India), Amgen, Inc. (US), Samsung Biologics (South Korea), Hospira Inc.(US), Mylan, Inc.(US), Celltrion (South Korea), to mention a few.

Latest Developments

March 2021

European Medicines Agency has given the green light to Kixelle, a biosimilar developed by Biocon Biologics Ltd., touted to be the fourth ever biosimilar insulin and the second fast-acting insulin analogue biosimilar to be introduced in the EU. Kixelle is a fast-acting biosimilar insulin analog that helps treat diabetes mellitus in adolescents, children and adults.

Read More @ https://www.marketresearchfuture.com/reports/biosimilars-market-1329

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Blog: https://healthcarenews12.blogspot.com/